SCHEMBL2032341

SCHEMBL2032341

CC(CNCCO)NCCO

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.39
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1741235 0.86 SIGMAR1 (0.32) SLC6A4
SCHEMBL10872778 0.82
SCHEMBL11549928 0.82 ANPEP (0.45) HSD17B10
SCHEMBL11555083 0.82 ANPEP (0.45) HSD17B10
SCHEMBL11551537 0.82 ANPEP (0.45) HSD17B10
SCHEMBL11555809 0.82 ANPEP (0.45) HSD17B10
SCHEMBL11557215 0.82 ANPEP (0.45) HSD17B10
SCHEMBL1742985 0.80
SCHEMBL25553525 0.78 TDP1 (0.32)
SCHEMBL9407525 0.76 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637439-B2 Preparation of cannabichromene and related cannabinoids BAYMEDICA, INC. (US) 2026-05-26 US claimed
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS BAYMEDICA, INC. 2023-03-02 US claimed
US-8911775-B2 pH-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE (KR) 2014-12-16 US claimed
EP-2340811-B1 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same UNIV SUNGKYUNKWAN FOUND (KR) 2014-10-15 EP claimed
US-8372892-B2 Attached, high reactivity rigid polyurethane foams DOW GLOBAL TECHNOLOGIES LLC (US) 2013-02-12 US claimed
EP-1725600-B2 ATTACHED, HIGH REACTIVITY RIGID POLYURETHANE FOAMS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-10-03 EP claimed
EP-2340811-A1 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same Sungkyunkwan University Foundation for Corporate Collaboration (KR) 2011-07-06 EP claimed
US-20110150978-A1 PH-SENSITIVE BLOCK COPOLYMER FORMING POLYIONIC COMPLEX MICELLES AND DRUG OR PROTEIN CARRIER USING THE SAME SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) 2011-06-23 US claimed
EP-1725600-B1 ATTACHED, HIGH REACTIVITY RIGID POLYURETHANE FOAMS DOW GLOBAL TECHNOLOGIES INC (US) 2008-09-03 EP claimed
US-20080038461-A1 Attached, High Reactivity Rigid Polyurethane Foams DOW GLOBAL TECHNOLOGIES LLC 2008-02-14 US claimed
US-12637439-B2 Preparation of cannabichromene and related cannabinoids BAYMEDICA, INC. (US) 2026-05-26 US disclosed
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS BAYMEDICA, INC. 2023-03-02 US disclosed
WO-2022071514-A1 ADHESIVE, CURED PRODUCT, AND LAMINATE 東洋インキSCホールディングス株式会社 2022-04-07 WO disclosed
US-10457820-B2 Alcohol-based printing ink composition TOYO INK SC HOLDINGS CO., LTD. (JP) 2019-10-29 US disclosed
US-9523009-B2 Alcohol-based printing ink composition TOYO INK SC HOLDINGS CO., LTD. (JP) 2016-12-20 US disclosed
US-4677136-A MOLDING MATERIALS BAYER AKTIENGESELLSCHAFT (DE) 1987-06-30 US disclosed
US-4469856-A Non-crystalline polyamine/carbonic acid salt compositions, a process for their preparation and their use for the production of polyurethane ureas, especially foamed coatings BAYER AKTIENGESELLSCHAFT (DE) 1984-09-04 US disclosed
US-4252604-A OPTICAL BRIGHTENERS SANDOZ LTD. (CH) 1981-02-24 US disclosed
US-4077920-A Flame- and smoke-resistant polyurethane foam and a method for producing said foam BRIDGESTONE TIRE COMPANY LIMITED (JA) 1978-03-07 US disclosed
US-4073687-A PENICILLINS OR CEPHALOSPORINS SHIONOGI & CO., LTD. (JA) 1978-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637439-B2 Preparation of cannabichromene and related cannabinoids CNR2, CNR1, OPRM1 SLC6A4 1353/4885HSD17B10 648/4885
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS CNR2, CNR1, SQLE SLC6A4 3543/4885HSD17B10 2268/4885
US-20110150978-A1 PH-SENSITIVE BLOCK COPOLYMER FORMING POLYIONIC COMPLEX MICELLES AND DRUG OR PROTEIN CARRIER USING THE SAME CHMP4B, PEBP1, ABCC1 SLC6A4 1593/4885HSD17B10 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.